A major event occurring in 2015 is the “Spin-off” of NIT Enterprises. NIT is currently a wholly-owned subsidiary of Radiant Creations.
NIT holds our proprietary Nucleotide Patent and Patent Pending technologies. Radiant will file a Form S-1 Registration Statement for NIT’s Initial Public Offering (IPO) in early 2015, which is the first major step in making NIT Enterprises its own public company through a “Spin-off”.
As a Radiant Shareholder, you will be the beneficiary of this “Spin-off” through the issuance of a share dividend issued by NIT Enterprises.
Our goal is to have a tightly-held share structure that provides for a limited number of outstanding shares and an elevated share price upon issuance of NIT’s trading symbol.
Upon final approval from the SEC and FINRA, it is intended that Radiant Shareholders will be issued shares in NIT at a ratio of 1-for-10.
For example, if you have 100,000 shares of Radiant you will be issued 10,000 shares of NIT.